Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Parallel-group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects With Diabetes Mellitus
Conditions
Interventions
DSC127
placebo vehicle gel
Locations
25
United States
WILMAX Clinical Research Inc
Mobile, Alabama, United States
Center for Clinical Research
Fair Oaks, California, United States
Roy O Kroeker, DPM, Inc
Fresno, California, United States
Foot and Ankle Clinic
Los Angeles, California, United States
Brian O'Carroll, DPM, Inc.
Pismo Beach, California, United States
UCLA Medical Center - Olive View
Sylmar, California, United States
Start Date
February 1, 2013
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
December 12, 2017
NCT07198061
NCT07193992
NCT06873646
NCT06747377
NCT05747872
NCT04945161
Lead Sponsor
Integra LifeSciences Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions